Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P105/poly(caprolactone) copolymers

Pharmazie

Volumn 63, Issue 6, 2008, Pages 446-452

  Wang, Yongzhong ^a,b   Li, Yajuan ^a   Wang, Qisong ^a   Fang, Xiaoling ^a  

^a FUDAN UNIVERSITY   (China)

^b ANHUI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; DRUG CARRIER; PACLITAXEL; PLURONIC P 105; POLOXAMER; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG RELEASE; DRUG RETENTION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIGHT SCATTERING; MICELLE; MOUSE; NONHUMAN; OVARY; RAT; SPLEEN; TISSUE DISTRIBUTION; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; FEMALE; INDICATORS AND REAGENTS; MICE; MICELLES; MODELS, STATISTICAL; PACLITAXEL; POLOXAMER; POLYESTERS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION;

EID: 46849103632     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7312     Document Type: Article

References (23)

1. Alakhov V, Klinski E, Li SM, Pietrzynski G, Venne A, Batrakova E, Bro-nitch T, Kabanov A (1999) Block copolymer-based formulation of dox-orubicin. From cell screen to clinical trials. Colloids Surf B Biointer-faces 16: 113-134.
2. Batrakova EV, Li S, Li YL, Alakhov VY, Elmquist WF, Kabanov AV (2004) Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Release 100: 389-397.
3. Cho YW, Lee J, Lee SC, Huh KM, Park K (2004) Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release 97: 249-257.
4. Dunn SE, Coombes AGA, Garnett MC, Davis SS, Davies MC, Ilium L (1997) In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J Control Release 44: 65-76.
5. Gao Z, Fain HD, Rapoport N (2004) Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharm 1: 317-330.
6. Gao ZG, Fain HD, Rapoport N (2005) Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release 102: 203-222.
7. Ge H, Hu Y, Jiang X, Cheng D, Yuan Y, Bi H, Yang C (2002) Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethyleneoxide)-poly(epsilon-ca-prolactone) amphiphilic triblock copolymer micelles. J Pharm Sci 91: 1463-1473.
8. Grindel JM, Jaworski T, Piraner O, Emanuele RM, Balasubramanian M (2002) Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. J Pharm Sci 91: 1936-1947.
9. Ha JC, Kim SY, Lee YM (1999) Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - I. Preparation and characterization. J Control Release 62: 381-392.
10. Han LM, Guo J, Zhang LJ, Wang QS, Fang XL (2006) Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123. Acta Pharmacol Sin 27: 747-753.
11. Illum L, Jacobsen LO, Muller RH, Mak E, Davis SS (1987) Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8: 113-117.
12. Jones MC, Leroux JC (1999) Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm 48: 101-111.
13. Kabanov AV, Alakhov VY (2002) Pluronic (R) block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst 19: 1-72.
14. Kim SY, Ha JC, Lee YM (2000) Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - II. Thermo-responsive drug release behaviors. J Control Release 65: 345-358.
15. Kim SY, Lee YM (2001) Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials 22: 1697-1704.
16. Kumar N, Ravikumar MNV, Domb AJ (2001) Biodegradable block copolymers. Adv Drag Deliv Rev 53: 23-44.
17. Lin WJ, Chen YC, Lin CC, Chen CF, Chen JW (2006) Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and bio- distribution studies. J Biomed Mater Res B Appl Biomater 77: 188-194.
18. Liu H, Farrell S, Uhrich K (2000) Drag release characteristics of unimole-cular polymeric micelles. J Control Release 68: 167-174.
19. Rowinsky EK, Donehower RC (1993) The clinical pharmacology of pacli-taxel (Taxol). Semin Oncol 20 (4 Suppl 3): 16-25.
20. Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332: 1004-1014.
21. Suh H, Jeong B, Rathi R, Kim SW (1998) Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/gly- colide) nanospheres. J Biomed Mater Res 42: 331-338.
22. Wang Y, Yu L, Han L, Sha X, Fang X (2007) Difunctional Pluronic copolymer micelles for paclitaxel delivery: Synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm 337: 63-73.
23. Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I (2005) Development and characterization of a novel Cremophor (R) EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59: 177-187.